Assoc. Prof. Dr. Nermeen Mohamed Sayed Ahmed Badr Elbakary | Nuclear Physics | Research Excellence Award
Associate professor | Egyptian Atomic Energy Authority | Egypt
Assoc. Prof. Dr. Nermeen Mohamed Sayed Ahmed Badr Elbakary is a distinguished researcher recognized for her impactful scientific contributions and advanced work in radiobiology, radiation biochemistry, radioprotection, and translational cancer research within the broader sphere of Nuclear Physics applications. Her research output reflects a strong foundation in experimental radiation science and therapeutic modulation, anchored in Nuclear Physics principles and developed through extensive laboratory, preclinical, and molecular investigations. She has established a significant academic footprint through peer-reviewed publications, collaborative research activities, and innovative projects that support safe and beneficial integration of Nuclear Physics in medicine, health, and radiation-based disease management. Her professional trajectory demonstrates leadership in the interface between biochemical systems and ionizing radiation mechanisms, bringing the precision of Nuclear Physics into cancer therapy, oxidative stress regulation, radiotracer development, radiosensitization, and tissue-protective strategies. Her multidisciplinary approach links biochemical pathways, immune regulation, molecular signaling, and toxicological markers with radiation exposure outcomes, reinforcing the translational value of Nuclear Physics in understanding cellular responses and advancing therapeutic interventions. Through research collaborations across biochemistry, molecular oncology, pharmacology, and imaging sciences, she has contributed to improved diagnostic and therapeutic solutions that benefit public health and global scientific progress. Her publications, experimental investigations, and continuous participation in scientific conferences reflect her commitment to expanding knowledge in Nuclear Physics, supporting the development of new radioprotectants, natural compounds, radiopharmaceuticals, and imaging tools. Her academic service includes research supervision, manuscript review for recognized journals, laboratory and project management, and active contribution to scientific communities working in radiation-linked biomedical innovation. Her work strengthens the strategic role of Nuclear Physics in clinical safety, cancer therapeutics, biological protection, and medical advancement, generating outcomes of scientific and societal importance. Her Google Scholar profile indicates 327 Citations, 12 h-index, 12 i10-index.
Profiles: Google Scholar | ORCID
Featured Publications
1. El Bakary, N. M., Alsharkawy, A. Z., Shouaib, Z. A., & Barakat, E. M. S. (2020). Role of bee venom and melittin on restraining angiogenesis and metastasis in γ-irradiated solid Ehrlich carcinoma-bearing mice. Integrative Cancer Therapies, 19, 1534735420944476.
2. Medhat, A. M., Azab, K. S., Said, M. M., El Fatih, N. M., & El Bakary, N. M. (2017). Antitumor and radiosensitizing synergistic effects of apigenin and cryptotanshinone against solid Ehrlich carcinoma in female mice. Tumor Biology, 39(10), 1010428317728480.
3. Hafez, E. N., Moawed, F. S. M., Abdel-Hamid, G. R., & Elbakary, N. M. (2020). Gamma radiation-attenuated Toxoplasma gondii provokes apoptosis in Ehrlich ascites carcinoma-bearing mice generating long-lasting immunity. Technology in Cancer Research & Treatment, 19, 1533033820926593.
4. Azab, K. S., Maarouf, R. E., Abdel-Rafei, M. K., El Bakary, N. M., & Thabet, N. M. (2022). Withania somnifera (Ashwagandha) root extract counteract acute and chronic impact of γ-radiation on liver and spleen of rats. Human & Experimental Toxicology, 41, 09603271221106344.
5. Elbakry, M. M. M., ElBakary, N. M., Hagag, S. A., & Hemida, E. H. A. (2023). Pomegranate peel extract sensitizes hepatocellular carcinoma cells to ionizing radiation, induces apoptosis and inhibits MAPK, JAK/STAT3, β-catenin/NOTCH, and SOCS3 signaling. Integrative Cancer Therapies, 22, 15347354221151021.